Skip to main content
Fig. 6 | Journal for ImmunoTherapy of Cancer

Fig. 6

From: Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Fig. 6

Efficacy of combination therapy is similarly observed in a subcutaneous lung cancer model. Combination therapy was tested in the murine LLC lung cancer model. Tumors were allowed to grow to an average of 100mm3 per group before initiation of treatment (red arrow). Average fold change of tumor volume of mice treated with combination therapy (Combo), chemotherapy (Chemo) alone, or immunotherapy (IT) alone as well as vehicle only (Vehicle). The number of mice per group (n) are listed. All experiments were performed with biological replicates twice. Statistics were calculated using two-way ANOVA and the Log-rank (Mantel-Cox) test. * p ≤ 0.05, *** p ≤ 0.001, **** p ≤ 0.0001

Back to article page